Covid-19: Clinical Trials to Start on Colchicine by Hannah Joy on June 14, 2021 at 1:47 PM
Colchicine drug is gonna undergo a two-arm phase-II clinical trial by the Council of Scientific and Industrial Research (CSIR) to assess the safety and efficacy of the drug in treating Covid-19.
Colchicine is used for treating gout and related inflammatory conditions. The drug is expected to be an important therapeutic intervention for Covid patients with cardiac co-morbidities.
A number of global studies have confirmed now that cardiac complications during course of Covid-19 infections and post-Covid syndrome are leading to loss of many lives, and it is essential to look for new or repurposed drugs.
The Council of Scientific and Industrial Research (CSIR) will undertake a two-arm phase-II clinical trial to assess the safety and efficacy of the drug Colchicine for the treatment of Covid-19 patients.Colchicine is used for treating gout and .
Read more about Regulatory nod given to conduct clinical trials of Colchicine: CSIR on Business Standard. The Drugs Controller General of India (DCGI) has given approval to the CSIR and Laxai Life Sciences Private Limited to conduct clinical trial of Colchicine on COVID-19 patients, according to a statement on Saturday.Ram Vishwakarma, the advisor to
The Drugs Controller General of India (DCGI) has given approval to the CSIR and Laxai Life Sciences Private Limited to conduct a clinical trial of Colchicine on COVID-19 patients.